AF Cohen

2.4k total citations
31 papers, 1.0k citations indexed

About

AF Cohen is a scholar working on Cellular and Molecular Neuroscience, Cognitive Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, AF Cohen has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 12 papers in Cognitive Neuroscience and 10 papers in Psychiatry and Mental health. Recurrent topics in AF Cohen's work include Neuroscience and Neuropharmacology Research (10 papers), Epilepsy research and treatment (7 papers) and Cannabis and Cannabinoid Research (4 papers). AF Cohen is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Epilepsy research and treatment (7 papers) and Cannabis and Cannabinoid Research (4 papers). AF Cohen collaborates with scholars based in Netherlands, United States and United Kingdom. AF Cohen's co-authors include Rik C. Schoemaker, Joop van Gerven, JMA van Gerven, Saco J. de Visser, G. Land, Landon Ashby, Glenn Dumont, Kari L. Franson, Lineke Zuurman and David C. Crowley and has published in prestigious journals such as Blood, American Journal of Clinical Nutrition and Epilepsia.

In The Last Decade

AF Cohen

29 papers receiving 992 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
AF Cohen Netherlands 17 373 294 258 253 170 31 1.0k
L Linzmayer Austria 21 293 0.8× 219 0.7× 371 1.4× 289 1.1× 111 0.7× 84 1.2k
Jan Grace United Kingdom 12 242 0.6× 277 0.9× 277 1.1× 198 0.8× 250 1.5× 22 1.2k
Stephen M. Stahl United States 20 289 0.8× 285 1.0× 332 1.3× 562 2.2× 155 0.9× 44 1.5k
A. Klimke Germany 22 286 0.8× 247 0.8× 416 1.6× 709 2.8× 174 1.0× 79 1.7k
Jack Hirschowitz United States 22 272 0.7× 164 0.6× 209 0.8× 812 3.2× 136 0.8× 63 1.4k
Ilja Spellmann Germany 21 207 0.6× 222 0.8× 176 0.7× 581 2.3× 200 1.2× 36 1.7k
Susan M. Learned United States 15 259 0.7× 255 0.9× 105 0.4× 219 0.9× 175 1.0× 22 1.1k
Massimo Carlo Mauri Italy 21 350 0.9× 372 1.3× 116 0.4× 851 3.4× 135 0.8× 60 1.5k
Hollister Le United States 15 453 1.2× 491 1.7× 148 0.6× 223 0.9× 150 0.9× 67 1.1k
E. Tempesta Italy 18 342 0.9× 120 0.4× 157 0.6× 104 0.4× 178 1.0× 49 1.1k

Countries citing papers authored by AF Cohen

Since Specialization
Citations

This map shows the geographic impact of AF Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AF Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AF Cohen more than expected).

Fields of papers citing papers by AF Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AF Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AF Cohen. The network helps show where AF Cohen may publish in the future.

Co-authorship network of co-authors of AF Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of AF Cohen. A scholar is included among the top collaborators of AF Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with AF Cohen. AF Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Iannone, Raffaele, B.R. Bloem, John Palcza, et al.. (2011). The effects of a novel histamine-3 receptor inverse agonist on essential tremor in comparison to stable levels of alcohol. Journal of Psychopharmacology. 26(2). 292–302. 16 indexed citations
3.
4.
Zuurman, Lineke, et al.. (2009). Pharmacodynamic and pharmacokinetic effects of the intravenous CB1 receptor agonist Org 26828 in healthy male volunteers. Journal of Psychopharmacology. 24(11). 1689–1696. 6 indexed citations
5.
Haas, Sanne Lysbet de, Saco J. de Visser, M. De Smet, et al.. (2006). Pharmacodynamic and pharmacokinetic effects of TPA023, a GABAAα2,3subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers. Journal of Psychopharmacology. 21(4). 374–383. 74 indexed citations
6.
Dumont, Glenn, Saco J. de Visser, AF Cohen, & Joop van Gerven. (2005). Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects. British Journal of Clinical Pharmacology. 59(5). 495–510. 85 indexed citations
7.
8.
Visser, Saco J. de, et al.. (2003). REM Sleep Effects as a Biomarker for the Effects of Antidepressants in Healthy Volunteers. Journal of Psychopharmacology. 17(2). 196–203. 25 indexed citations
9.
Franson, Kari L., et al.. (2002). REM sleep reduction as a biomarker for the effects of antidepressants in healthy volunteers. British Journal of Clinical Pharmacology. 54(5). 561–561. 4 indexed citations
10.
Post, Joris van der, Miranda T. Schram, Rik C. Schoemaker, et al.. (2002). Cns Effects of Sumatriptan and Rizatriptan in Healthy Female Volunteers. Cephalalgia. 22(4). 271–281. 16 indexed citations
11.
Visser, Saco J. de, Joop van Gerven, Rik C. Schoemaker, & AF Cohen. (2001). Concentration‐effect relationships of two infusion rates of the imidazoline antihypertensive agent rilmenidine for blood pressure and development of side‐effects in healthy subjects. British Journal of Clinical Pharmacology. 51(5). 423–428. 12 indexed citations
12.
Steveninck, Alfred L van, et al.. (1999). The sensitivity of pharmacodynamic tests for the central nervous system effects of drugs on the effects of sleep deprivation. Journal of Psychopharmacology. 13(1). 10–17. 90 indexed citations
13.
Burggraaf, J., Aernout D. van Haarst, Paul Fockens, et al.. (1998). The gastrointestinal passage and release of beclomethasone dipropionate from oral delivery systems in ileostomy volunteers. British Journal of Clinical Pharmacology. 46(3). 207–214.
14.
Tijssen, Marina A.J., et al.. (1997). The effects of clonazepam and vigabatrin in hyperekplexia. Journal of the Neurological Sciences. 149(1). 63–67. 47 indexed citations
15.
Rooij, Frank J.A. van, Rik C. Schoemaker, Cor D. de Kroon, et al.. (1995). A placebo-controlled parallel study of the effect of two types of coffee oil on serum lipids and transaminases: identification of chemical substances involved in the cholesterol-raising effect of coffee. American Journal of Clinical Nutrition. 61(6). 1277–1283. 38 indexed citations
16.
Hamilton, M. J., AF Cohen, Alan W.C. Yuen, et al.. (1993). Carbamazepine and Lamotrigine in Healthy Volunteers: Relevance to Early Tolerance and Clinical Trial Dosage. Epilepsia. 34(1). 166–173. 56 indexed citations
17.
Soons, P.A., AF Cohen, & D.D. Breimer. (1993). Comparative effects of felodipine, nitrendipine and nifedipine in healthy subjects: concentration-effect relationships of racemic drugs and enantiomers. European Journal of Clinical Pharmacology. 44(2). 113–120. 6 indexed citations
18.
Tuk, Bert, et al.. (1993). A comparison of the concentration‐effect relationships of midazolam for EEG‐derived parameters and saccadic peak velocity.. British Journal of Clinical Pharmacology. 36(2). 109–115. 23 indexed citations
19.
Cohen, AF, et al.. (1989). Upper Airway Obstruction Secondary to Warfarin-Induced Sublingual Hematoma. Archives of Otolaryngology - Head and Neck Surgery. 115(6). 718–720. 64 indexed citations
20.
Cohen, AF, John Posner, Landon Ashby, Richard Smith, & A. W. Peck. (1984). A comparison of methods for assessing the sedative effects of diphenhydramine on skills related to car driving. European Journal of Clinical Pharmacology. 27(4). 477–482. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L Linzmayer Breakdown of academic impact, for papers by Jan Grace Breakdown of academic impact, for papers by Stephen M. Stahl Breakdown of academic impact, for papers by A. Klimke Breakdown of academic impact, for papers by Jack Hirschowitz Breakdown of academic impact, for papers by Ilja Spellmann Breakdown of academic impact, for papers by Susan M. Learned Breakdown of academic impact, for papers by Massimo Carlo Mauri Breakdown of academic impact, for papers by Hollister Le Breakdown of academic impact, for papers by E. Tempesta
Rankless by CCL
2026